5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one

C31H46N2O7 — CID 89097700

IUPAC5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
SMILESCON(C1C=C2CCC3C(CC[C@]4(C)[C@@H](c5ccc(=O)oc5)CC[C@]34O)[C@@]2(C)CC1)[C@H]1OC[C@H](N)C(O)C1(C)O
InChIInChI=1S/C31H46N2O7/c1-28-12-9-20(33(38-4)27-30(3,36)26(35)24(32)17-40-27)15-19(28)6-7-23-22(28)10-13-29(2)21(11-14-31(23,29)37)18-5-8-25(34)39-16-18/h5,8,15-16,20-24,26-27,35-37H,6-7,9-14,17,32H2,1-4H3/t20?,21-,22?,23?,24+,26?,27+,28+,29-,30?,31+/m1/s1
InChIKeyWGZMCQVLLZOHHK-SMXZUNRLSA-N
MW558.72 g/mol
LogP2.83
Rot. Bonds4

About 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one

5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one (PubChem CID 89097700) has the molecular formula C31H46N2O7 and a molecular weight of 558.72 g/mol. Its IUPAC name is 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one.

Molecular Properties

Compound Name5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
PubChem CID89097700
Molecular FormulaC31H46N2O7
Molecular Weight558.72 g/mol
Exact Mass558.33
IUPAC Name5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
SMILESCON(C1C=C2CCC3C(CC[C@]4(C)[C@@H](c5ccc(=O)oc5)CC[C@]34O)[C@@]2(C)CC1)[C@H]1OC[C@H](N)C(O)C1(C)O
InChIInChI=1S/C31H46N2O7/c1-28-12-9-20(33(38-4)27-30(3,36)26(35)24(32)17-40-27)15-19(28)6-7-23-22(28)10-13-29(2)21(11-14-31(23,29)37)18-5-8-25(34)39-16-18/h5,8,15-16,20-24,26-27,35-37H,6-7,9-14,17,32H2,1-4H3/t20?,21-,22?,23?,24+,26?,27+,28+,29-,30?,31+/m1/s1
InChIKeyWGZMCQVLLZOHHK-SMXZUNRLSA-N
XLogP2.83
TPSA138.62 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500558.72
LogP ≤ 52.83
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one?
The IUPAC name of 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one (CID 89097700) is 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one.
What is the SMILES notation for 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one?
The canonical SMILES for 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one is CON(C1C=C2CCC3C(CC[C@]4(C)[C@@H](c5ccc(=O)oc5)CC[C@]34O)[C@@]2(C)CC1)[C@H]1OC[C@H](N)C(O)C1(C)O.
What is the InChIKey of 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one?
The InChIKey is WGZMCQVLLZOHHK-SMXZUNRLSA-N. The full InChI is InChI=1S/C31H46N2O7/c1-28-12-9-20(33(38-4)27-30(3,36)26(35)24(32)17-40-27)15-19(28)6-7-23-22(28)10-13-29(2)21(11-14-31(23,29)37)18-5-8-25(34)39-16-18/h5,8,15-16,20-24,26-27,35-37H,6-7,9-14,17,32H2,1-4H3/t20?,21-,22?,23?,24+,26?,27+,28+,29-,30?,31+/m1/s1.
What are the key properties of 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one?
5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one has a molecular weight of 558.72 g/mol, XLogP of 2.83, 4 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(10R,13R,14S,17R)-3-[[(2S,5S)-5-amino-3,4-dihydroxy-3-methyloxan-2-yl]-methoxyamino]-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one is sourced from PubChem (CID 89097700), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).